Since our earlier publications suggested and found a GH effect on optic neuropathy, we have subsequently been actively recruited young subjects with GH excess and initiated treatment for GH excess as early as possible in an effort to see if long term GH excess morbidity could be averted with treatment. This evidence concerns the gene GH1 and optic nerve disorder.